<PAGE>
As filed with the Securities and Exchange Commission on April 17, 2000
================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
GENSTAR THERAPEUTICS CORPORATION
(Exact name of registrant as specified in its charter)
DELAWARE 33-0687976
(State of Incorporation) (I.R.S. Employer Identification No.)
10835 Altman Row, Suite 150
SAN DIEGO, CALIFORNIA 92121
(Address of principal executive offices) (Zip code)
Securities to be registered pursuant to Section 12(b) of the Act:
COMMON STOCK, $0.001 PAR VALUE THE AMERICAN STOCK EXCHANGE
(Name of each exchange on which
(Title of each class to be registered) each class is to be registered)
------------------------------------------------------------------
If this form relates to the registration of a class of securities pursuant
to Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), check the following box. [x]
If this form relates to the registration of a class of securities pursuant
to Section 12(g) of the Exchange Act and is effective pursuant to general
Instruction A.(d), check the following box. [_]
Securities Act registration statement file number to which this form relates:
N/A
Securities to be registered pursuant to Section 12(g) of the Act:
N/A
(Title of Class)
================================================================================
<PAGE>
ITEM 1. DESCRIPTION OF REGISTRANT'S SECURITIES TO BE REGISTERED.
Incorporated herein by reference to the "Description of Capital Stock"
section of Amendment No. 4 to the Company's Registration Statement on Form SB-2
filed February 10, 2000 (File No. 333-81283).
ITEM 2. EXHIBITS.
Exhibit No. Description
- ----------- -----------
1. Certificate of Incorporation of the Company, incorporated herein by
reference to Exhibit 3.1 to the Company's Registration Statement on
Form 10-SB filed February 9, 1996.
2. Bylaws of the Company, incorporated herein by reference to Exhibit
3.2 to the Company's Registration Statement on Form 10-SB filed
February 9, 1996.
3. Certificate of Designation of Preferences and Rights of Series A
Preferred Stock of the Company, incorporated herein by reference to
Exhibit 4.1 to the Company's Current Report on Form 8-K filed July
23, 1998.
4. Certificate of Designation of Preferences and Rights of Series B
Preferred Stock of the Company, incorporated herein by reference to
Exhibit 4.2 to the Company's Current Report on Form 8-K filed July
23, 1998.
5. Certificate of Designation of Preferences and Rights of Series C
Preferred Stock of the Company, incorporated herein by reference to
Exhibit 4.3 to the Company's Current Report on Form 8-K filed July
23, 1998.
6. Certificate of Amendment of the Restated Certificate of
Incorporation, incorporated herein by reference to Exhibit 3.1 to
the Company's Annual Report on Form 10-KSB filed March 30, 2000.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
GENSTAR THERAPEUTICS CORPORATION
Date: April 17, 2000 By: /s/ CARIN SANDVIK
---------------------------------------
Carin Sandvik, Corporate Controller and
Corporate Secretary
